
                                SEQUENCE LISTING

<110> Aligos Therapeutics, Inc.
      Vendeville, Sandrine
      Raboisson, Pierre Jean-Marie Bernard

<120> HETEROCYCLIC COMPOUNDS
  

<130> ALIG.021WO

<140> 62/858236           
<141> 2019-06-06  

<160> 4

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic HBV-forward primer

<400> 1
gtgtctgcgg cgttttatca                                             20

<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic HBV-reverse primer

<400> 2
gacaaacggg caacatacct t                                           21

<210> 3
<211> 28
<212> DNA
<213> Artificial Sequence

<220> 
<221> modified_base  
<222> 1
<223> N = FAM-C

<220> 
<221> modified_base  
<222> 28
<223> N = C-TAMRA

<220> 
<223> Synthetic HBV-probe

<400> 3
nctctkcatc ctgctgctat gcctcatn                                    28

<210> 4
<211> 28
<212> DNA
<213> Artificial Sequence

<220> 
<221> modified_base  
<222> 1
<223> N=FAM-C

<220> 
<221> modified_base  
<222> 9
<223> N=T-ZEN

<220> 
<221> modified_base  
<222> 28
<223> N = C-3AIBkFq

<220> 
<223> Synthetic HBV-probe

<400> 4
nctctkcanc ctgctgctat gcctcatn                                    28
